Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Microbiotica, a UK-based developer of microbiome-based therapeutics and biomarkers spun out of Wellcome Sanger Institute, completed a £50m ($66.6m) series B round backed by commercialisation firm IP Group and patient capital fund Cambridge Innovation Capital (CIC) today. The round included internet group Tencent, as well as Flerie Invest, British Patient Capital and Seventure Partners. Seventure previously injected $5.2m in 2018, two years after Microbiotica was established with $10m from CIC and IP Group.
Tenyks, a UK-based spinout of…
Thierry Heles
Thierry Heles is the editor of Global University Venturing, host of the Beyond the Breakthrough interview podcast and responsible for the monthly GUV Gazette (sign up here for free).
